Emerging Roles of Hedgehog Signaling in Cancer Immunity
International Journal of Molecular Sciences · 10.01.2023 · 24 (2) · 1321
DOI: 10.3390/ijms24021321 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.01.2023. Verfasst von Alessandro Giammona und 2 weiteren Autor:innen. Beteiligte Einrichtung: Core Research Laboratory, Institute for Cancer Research and Prevention (ISPRO), Viale Gaetano Pieraccini 6, 50139 Florence, Italy. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Skin Neoplasms, Cerebellar Neoplasms. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, Associazione Italiana per la Ricerca sul Cancro, ISPRO.
Abstract (Originalsprache)
Hedgehog–GLI (HH) signaling plays an essential role in embryogenesis and tissue homeostasis. Aberrant activation of the pathway through mutations or other mechanisms is involved in the development and progression of numerous types of cancer, including basal cell carcinoma, medulloblastoma, melanoma, breast, prostate, hepatocellular and pancreatic carcinomas. Activation of HH signaling sustains proliferation, suppresses cell death signals, enhances invasion and metastasis, deregulates cellular metabolism and promotes angiogenesis and tumor inflammation. Targeted inhibition of the HH pathway has therefore emerged as an attractive therapeutic strategy for the treatment of a wide range of cancers. Currently, the Smoothened (SMO) receptor and the downstream GLI transcriptional factors have been investigated for the development of targeted drugs. Recent studies have revealed that the HH signaling is also involved in tumor immune evasion and poor responses to cancer immunotherapy. Here we focus on the effects of HH signaling on the major cellular components of the adaptive and innate immune systems, and we present recent discoveries elucidating how the immunosuppressive function of the HH pathway is engaged by cancer cells to prevent immune surveillance. In addition, we discuss the future prospect of therapeutic options combining the HH pathway and immune checkpoint inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Core Research Laboratory, Institute for Cancer Research and Prevention (ISPRO), Viale Gaetano Pieraccini 6, 50139 Florence, Italy.
- Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 50100 Siena, Italy.
ORCID-Profile: Alessandro Giammona, Enrica Crivaro, Barbara Stecca
Förderung
- Italian Association for Cancer Research
- Associazione Italiana per la Ricerca sul Cancro
- ISPRO
Zitieren
APA
Giammona, A., Crivaro, E., & Stecca, B. (2023). Emerging Roles of Hedgehog Signaling in Cancer Immunity. International Journal of Molecular Sciences, 24(2), 1321. https://doi.org/10.3390/ijms24021321
Vancouver
Giammona A, Crivaro E, Stecca B. Emerging Roles of Hedgehog Signaling in Cancer Immunity. International Journal of Molecular Sciences. 2023;24(2):1321. doi:10.3390/ijms24021321
BibTeX
@article{Giammona2023,
author = {Giammona, Alessandro and Crivaro, Enrica and Stecca, Barbara},
title = {Emerging Roles of Hedgehog Signaling in Cancer Immunity},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {2},
pages = {1321},
doi = {10.3390/ijms24021321}
}
EUVIMED